Eluracat RSSAuthorisedThis medicine is authorised for use in the European Unioncapromorelin tartrateMedicineVeterinaryAuthorised
Page contents OverviewProduct detailsAuthorisation detailsAssessment historyNews on EluracatApplication under evaluationCVMP opinionEuropean Commission decisionOverviewUp-to-date information on this veterinary medicinal product is available on the Veterinary Medicines Information websiteProduct details Name of medicine Eluracat Active substance capromorelin tartrate International non-proprietary name (INN) or common name capromorelin tartrate Pharmacotherapeutic group Anterior pituitary lobe hormones and analogues Authorisation details EMA product number EMEA/V/C/005948 Assessment historyExpand sectionCollapse sectionChanges since initial authorisation of medicineCVMP post-authorisation summary of positive opinion for Eluracat (VRA-0002-G)AdoptedReference Number: EMA/CVMP/446484/2024 English (EN) (139.16 KB - PDF)First published: 11/10/2024ViewInitial marketing authorisation documentsCVMP summary of positive opinion for EluracatAdoptedReference Number: EMA/CVMP/194243/2023 English (EN) (129.4 KB - PDF)First published: 22/05/2023ViewNews on EluracatMeeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 8-10 October 202411/10/2024Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 16-18 July 202419/07/2024Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 15-16 May 202322/05/2023This page was last updated on 23/05/2024Share this page